Skip to main content
. Author manuscript; available in PMC: 2023 Nov 2.
Published in final edited form as: J Health Econ. 2016 Jun 22;49:28–45. doi: 10.1016/j.jhealeco.2016.06.004

Table 4.

Chronic and acute announcement and implementation effects.

Dependent variable:
Total prescriptions
Log(total prescriptions)
Classification method: >50% In drug group
>65% In drug group
>50% In drug group
>65% In drug group
(1) (2) (3) (4) (5) (6) (7) (8)

Chronic*Announce −1.5667*** −1.4160*** −0.0543 −0.1127***
(0.509) (0.444) (0.035) (0.036)
Chronic*Implement 3.5449*** 1.5100 3.2464*** 1.4074* 0.0088 −0.0618 0.0404 −0.1060*
(0.602) (0.924) (0.534) (0.807) (0.035) (0.058) (0.036) (0.060)
Announce −0.1567 −0.0322 −0.0179 0.0191
(0.159) (0.090) (0.026) (0.020)
Implement 0.9651*** 0.7608*** 0.3655*** 0.3230** 0.1547*** 0.1314*** 0.1031*** 0.1278***
(0.163) (0.264) (0.091) (0.151) (0.025) (0.042) (0.019) (0.033)
Chronic 16.2625*** 15.4795*** 12.9526*** 12.2450*** 1.4718*** 1.4447*** 1.5046*** 1.4483***
(0.474) (0.495) (0.404) (0.418) (0.031) (0.033) (0.033) (0.034)
t −0.0494 −0.0023 −0.0048 0.0049 −0.0187*** −0.0133 −0.0128*** −0.0185**
(0.041) (0.058) (0.023) (0.033) (0.006) (0.009) (0.005) (0.007)
Chronic*t 0.5777*** 1.0473*** 0.6883*** 1.1127*** 0.0419*** 0.0582*** 0.0551*** 0.0889***
(0.144) (0.196) (0.124) (0.168) (0.009) (0.013) (0.010) (0.013)
Announce + Chronic*Announce −1.7234*** −1.4481*** −0.0722** −0.0936***
(0.526) (0.441) (0.031) (0.032)
Implement + Chronic*Implement 4.5100*** 2.2707** 3.6119*** 1.7304** 0.1635*** 0.0697 0.1435*** 0.0218
(0.622) (0.957) (0.531) (0.802) (0.032) (0.053) (0.033) (0.054)
Observations 40,144 40,144 40,144 40,144 40,144 40,144 40,144 40,144

Notes:

***

p < 0.01

**

p < 0.05

*

p < 0.1.

Clustered standard errors at the person level. Regressions are weighted and include a full set of control variables. Medicaid beneficiaries are included. The bottom panel presents linear combinations of the coefficients and their standard errors to show absolute announcement and implementation effects for chronic drugs. The classification method presented is either the median assignment rule (more than 50% of drugs in the therapeutic class are either chronic or acute) or the assignment rule in which more than 65% of drugs in the class are either chronic or acute (classes with fewer than 65% of drugs in both groups are excluded). MCBS 2001–2006; Ages 66–74.